Edition:
United States

FibroGen Inc (FGEN.OQ)

FGEN.OQ on NASDAQ Stock Exchange Global Select Market

46.88USD
17 Nov 2017
Change (% chg)

$-0.22 (-0.48%)
Prev Close
$47.10
Open
$46.65
Day's High
$47.40
Day's Low
$45.75
Volume
145,657
Avg. Vol
231,466
52-wk High
$60.15
52-wk Low
$19.30

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Thomas Neff

62 Chairman of the Board, Chief Executive Officer, Founder

Pat Cotroneo

53 2008 Chief Financial Officer, Vice President - Finance

Frank Valone

66 2016 Senior Fellow, Clinical Development

K. Peony Yu

54 2016 Chief Medical Officer

Gerald Lema

2017 Director